211 related articles for article (PubMed ID: 31115853)
1. Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module.
Stolpner I; Heil J; Feißt M; Karsten MM; Weber WP; Blohmer JU; Forster T; Golatta M; Schütz F; Sohn C; Hennigs A
Ann Surg Oncol; 2019 Sep; 26(9):2759-2767. PubMed ID: 31115853
[TBL] [Abstract][Full Text] [Related]
2. Validation of the electronic version of the BREAST-Q in the army of women study.
Fuzesi S; Cano SJ; Klassen AF; Atisha D; Pusic AL
Breast; 2017 Jun; 33():44-49. PubMed ID: 28279888
[TBL] [Abstract][Full Text] [Related]
3. Psychometric validation of the Breast Cancer Treatment Outcome Scale (BCTOS-12): a prospective cohort study.
Feißt M; Heil J; Stolpner I; von Au A; Domschke C; Sohn C; Kieser M; Rauch G; Hennigs A
Arch Gynecol Obstet; 2019 Dec; 300(6):1679-1686. PubMed ID: 31705285
[TBL] [Abstract][Full Text] [Related]
4. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction.
Winters ZE; Afzal M; Rutherford C; Holzner B; Rumpold G; da Costa Vieira RA; Hartup S; Flitcroft K; Bjelic-Radisic V; Oberguggenberger A; Panouilleres M; Mani M; Catanuto G; Douek M; Kokan J; Sinai P; King MT;
Br J Surg; 2018 Feb; 105(3):209-222. PubMed ID: 29116657
[TBL] [Abstract][Full Text] [Related]
5. Measuring breast cancer-specific health-related quality of life in South Asia: psychometric properties of the Sinhala version of the EORTC QLQ-BR23.
Jayasekara H; Rajapaksa LC; Brandberg Y
Qual Life Res; 2008 Aug; 17(6):927-32. PubMed ID: 18500576
[TBL] [Abstract][Full Text] [Related]
6. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
Kontodimopoulos N; Ntinoulis K; Niakas D
Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and satisfaction after breast cancer operation.
Han J; Grothuesmann D; Neises M; Hille U; Hillemanns P
Arch Gynecol Obstet; 2010 Jul; 282(1):75-82. PubMed ID: 19960349
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of the BREAST-Q Breast-Conserving Therapy Module.
Klassen AF; Dominici L; Fuzesi S; Cano SJ; Atisha D; Locklear T; Gregorowitsch ML; Tsangaris E; Morrow M; King T; Pusic AL
Ann Surg Oncol; 2020 Jul; 27(7):2238-2247. PubMed ID: 31965369
[TBL] [Abstract][Full Text] [Related]
9. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
Gadisa DA; Gebremariam ET; Ali GY
Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
[TBL] [Abstract][Full Text] [Related]
11. [Validity and reliability of the quality of life questionnaire (EORTC QLQ C30) and its breast cancer module (EORTC QLQ BR23)].
Zawisza K; Tobiasz-Adamczyk B; Nowak W; Kulig J; Jedrys J
Ginekol Pol; 2010 Apr; 81(4):262-7. PubMed ID: 20476597
[TBL] [Abstract][Full Text] [Related]
12. Development of a Japanese version of the BREAST-Q and the traditional psychometric test of the mastectomy module for the assessment of HRQOL and patient satisfaction following breast surgery.
Saiga M; Taira N; Kimata Y; Watanabe S; Mukai Y; Shimozuma K; Mizoo T; Nogami T; Iwamoto T; Motoki T; Shien T; Matsuoka J; Doihara H
Breast Cancer; 2017 Mar; 24(2):288-298. PubMed ID: 27179527
[TBL] [Abstract][Full Text] [Related]
13. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study.
Arndt V; Stegmaier C; Ziegler H; Brenner H
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1311-8. PubMed ID: 18504613
[TBL] [Abstract][Full Text] [Related]
14. Validation and reliability testing of the Breast-Q latissimus dorsi questionnaire: cross-cultural adaptation and psychometric properties in a Swedish population.
Kamya L; Hansson E; Weick L; Hansson E
Health Qual Life Outcomes; 2021 Jul; 19(1):174. PubMed ID: 34217326
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cosmetic outcome following breast-conserving therapy in trials: panel versus digitalized analysis and the role of PROMs.
Lagendijk M; Vos EL; Nieboer D; Verhoef C; Corten EML; Koppert LB
Breast J; 2018 Jul; 24(4):519-525. PubMed ID: 29316049
[TBL] [Abstract][Full Text] [Related]
16. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
17. Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures.
Chen CM; Cano SJ; Klassen AF; King T; McCarthy C; Cordeiro PG; Morrow M; Pusic AL
Breast J; 2010; 16(6):587-97. PubMed ID: 21070435
[TBL] [Abstract][Full Text] [Related]
18. Satisfaction with the Aesthetic Effect and Quality of Life for Women after Breast Conserving Therapy (BCT)-Preliminary Research.
Krzos A; Stanisławek A; Jędrych M; Łuczyk M; Ślusarska B
Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31775229
[TBL] [Abstract][Full Text] [Related]
19. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
20. Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™.
Dahlbäck C; Ullmark JH; Rehn M; Ringberg A; Manjer J
Breast Cancer Res Treat; 2017 Aug; 164(3):679-687. PubMed ID: 28536951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
